At the same time, SREBP-1 is the master regulator of de novo fatty acid biosynthesis and implicated in hepatic steatosis through upregulation of expression of many lipogenic genes, including Scd1 and Elovl5, leading to elevated plasma and liver TC levels (Kim et al., 2015). This evidence concerns the gene ELOVL5 and fatty liver disease.